Editorial · 13 May 2026
Review articlePublished 29 Dec 2017
The impact of Renin-angiotensin system blockers on lung cancers prognosis: A prisma-compliant systematic review and meta-analysis.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background and objective: The impact of antihypertensive medications angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) on the clinical outcomes of lung cancer patients remains controversial. This meta-analysis was conducted to investigate the association between ACEIs/ARBs usage and survival of lung cancer patients. Methods: Eligible studies were identified by searching Pubmed, Embase and Cochrane library up to February, 2017. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for the effect of ACEIs/ARBs on survival of lung cancer. Heterogeneity and sensitivity were also analyzed. Results: We finally included 9 eligible studies (8 articles) with the total number of 29,156 patients in this meta-analysis. Our results showed that ACEIs/ARBs usage was associated with favorable overall survival (OS) (HR, 0.86; 95% CI, 0.76–0.98) in lung cancer patients. Moreover, the significant association was found in subgroup of advanced clinical stage (IIIb to IV) (HR, 0.77; 95% CI, 0.64-0.92) and non-small cell lung carcinoma (NSCLC) (HR, 0.78; 95% CI, 0.65–0.93). However, no significant association was revealed between ACEIs/ARBs usage and progression-free survival (PFS) (HR, 0.84; 95% CI, 0.70–1.02). Conclusions: ACEIs/ARBs statistically significantly prolong OS of lung cancer patients, especially in advanced clinical stage or patients with NSCLC. However, it has no demonstrable impact on PFS.
Keywords
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Allied Journal of Medical Research.
Editorial · 13 May 2026
Advancements in neurological research and treatment
Editorial · 13 May 2026
Molecular biology and medicine: Diverse research for health.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAllied Journal of Medical Research
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Ning Wang”
- BylineArticles whose byline prints “Jia Liu”
- BylineArticles whose byline prints “Wenting Wang”
- BylineArticles whose byline prints “Jinguang Qin”
- BylineArticles whose byline prints “Dianjie Lin”
